nach oben

Molecular Imaging and Biology

Erschienen in:

24.01.2019 | Special Topic

Summary of Imaging in 2020: Visualizing the Future of Healthcare with MR Imaging

verfasst von: Brooke A. Corbin, Alyssa C. Pollard, Matthew J. Allen, Mark D. Pagel

Erschienen in: Molecular Imaging and Biology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

The Imaging in 2020 meeting convenes biannually to discuss innovations in medical imaging. The 2018 meeting, titled “Visualizing the Future of Healthcare with MR Imaging,” sought to encourage discussions of the future goals of MRI research, feature important discoveries, and foster scientific discourse between scientists from a variety of fields of expertise. Here, we highlight presented research and resulting discussions of the meeting.

www.imagingin2020.com. Accessed 26 Nov 2018

Wahsner J, Gale EM, Rodríguez-Rodríguez A, Caravan P (2018) Chemistry of MRI contrast agents: current challenges and new frontiers. Chem Rev. https://doi.org/10.1021/acs.chemrev.8b00363

Helm L, Morrow JR, Bond CJ et al (2018) Gadolinium-based contrast agents. In: Pierre VC, Allen MJ (eds) Contrast agents for MRI: experimental methods. The Royal Society of Chemistry, Croydon, pp 121–242

Young SW, Qing F, Harriman A, Sessler JL et al (1996) Gadolinium (III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI. Proc Natl Acad Sci U S A 93:6610–6615CrossRefPubMedPubMedCentral

Raymond KN, Pierre VC (2005) Next generation, high relaxivity gadolinium MRI agents. Bioconjug Chem 16:3–8CrossRefPubMed

Kanda T, Fukusato T, Matsuda M et al (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276:228–232CrossRefPubMed

Kanda T, Osawa M, Oba H et al (2015) High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 275:803–809CrossRefPubMed

Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834–841CrossRefPubMed

McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–782CrossRefPubMed

10.

Kanal E, Tweedle MF (2015) Residual or retained gadolinium: practical implications for radiologists and our patients. Radiology 275:630–634CrossRefPubMed

11.

Grobner T (2006) Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108CrossRefPubMed

12.

Andreucci M, Solomon R, Tasanarong A (2014) Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int 2014:741018PubMedPubMedCentral

13.

Thomsen HS (2009) Nephrogenic systemic fibrosis: history and epidemiology. Radiol Clin N Am 47:827–831CrossRefPubMed

14.

Wilson J, Gleghorn K, Seigel Q, Kelly B (2017) Nephrogenic systemic fibrosis: a 15-year retrospective study at a single tertiary care center. J Am Acad Dermatol 77:235–240CrossRefPubMed

15.

Wang Y, Alkasab TK, Narin O et al (2011) Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology 260:105–111CrossRefPubMed

16.

Cacheris WP, Quay SC, Rocklage SM (1990) The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 8:467–481CrossRefPubMed

17.

Wedeking P, Kumar K, Tweedle MF (1992) Dissociation of gadolinium chelates in mice: relationship to chemical characteristics. Magn Reson Imaging 10:641–648CrossRefPubMed

18.

Idée J-M, Port M, Raynal I et al (2006) Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 20:563–576CrossRefPubMed

19.

Sherry AD, Caravan P, Lenkinski RE (2009) Primer on gadolinium chemistry. J Magn Reson Imaging 30:1240–1248CrossRefPubMedPubMedCentral

20.

Frenzel T, Lengsfeld P, Schirmer H et al (2008) Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 °C. Investig Radiol 43:817–828CrossRef

21.

Cai J, Shapiro EM, Hamilton AD (2009) Self-assembling DNA quadruplex conjugated to MRI contrast agents. Bioconjug Chem 20:205–208CrossRefPubMedPubMedCentral

22.

Caravan P, Das B, Dumas S et al (2007) Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew Chem Int Ed 46:8171–8173CrossRef

23.

Farrar CT, DePeralta DK, Day H et al (2015) 3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model. J Hepatol 63:689–696CrossRefPubMedPubMedCentral

24.

Pu F, Qiao J, Xue S et al (2015) GRPR-targeted protein contrast agents for molecular imaging of receptor expression in cancers by MRI. Sci Rep 5:16214CrossRefPubMedPubMedCentral

25.

Boros E, Gale EM, Caravan P (2015) MR imaging probes: design and applications. Dalton Trans 44:4804–4818CrossRefPubMedPubMedCentral

26.

Lauffer RB (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 87:901–927CrossRef

27.

Loehr JA, Stinnett GR, Hernández-Rivera M et al (2016) Eliminating Nox2 reactive oxygen species production protects dystrophic skeletal muscle from pathological calcium influx assessed in vivo by manganese-enhanced magnetic resonance imaging. J Physiol 594:6395–6405CrossRefPubMedPubMedCentral

28.

Gale EM, Mukherjee S, Liu C et al (2014) Structure–redox–relaxivity relationships for redox responsive manganese-based magnetic resonance imaging probes. Inorg Chem 53:10748–10761CrossRefPubMedPubMedCentral

29.

Gale EM, Atanasova IP, Blasi F et al (2015) A manganese alternative to gadolinium for MRI contrast. J Am Chem Soc 137:15548–15557CrossRefPubMedPubMedCentral

30.

Gale EM, Caravan P (2018) Gadolinium-free contrast agents for magnetic resonance imaging of the central nervous system. ACS Chem Neurosci 9:395–397CrossRefPubMed

31.

Crossgrove J, Zheng W (2004) Manganese toxicity upon overexposure. NMR Biomed 17:544–553CrossRefPubMedPubMedCentral

32.

Jiang Y, Zheng W, Long L et al (2007) Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure. NeuroToxicology 28:126–135CrossRefPubMed

33.

Finney K-LNA, Harnden AC, Rogers NJ et al (2017) Simultaneous triple imaging with two PARASHIFT probes: encoding anatomical, pH and temperature information using magnetic resonance shift imaging. Chem Eur J 23:7976–7989CrossRefPubMed

34.

Bleaney B (1972) Nuclear magnetic resonance shifts of solution due to lanthanide ions. J Magn Reson 8:91–100

35.

Suturina EA, Mason K, Geraldes CFGC et al (2017) Beyond Bleaney’s theory: experimental and theoretical analysis of periodic trends in lanthanide-induced chemical shift. Angew Chem Int Ed 56:12215–12218CrossRef

36.

Ward KM, Aletras AH, Balaban RS (2000) A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 143:79–87CrossRefPubMed

37.

Thorarinsdottir AE, Du K, Collins JHP, Harris TD (2017) Ratiometric pH imaging with a Co^II ₂ MRI probe via CEST effects of opposing pH dependences. J Am Chem Soc 139:15836–15847CrossRefPubMed

38.

Jeon I-R, Park JG, Haney CR, Harris TD (2014) Spin crossover iron (II) complexes as PARACEST MRI thermometers. Chem Sci 5:2461–2465CrossRef

39.

Du K, Harris TD (2016) A Cu^II ₂ paramagnetic chemical exchange saturation transfer contrast agent enabled by magnetic exchange coupling. J Am Chem Soc 138:7804–7807CrossRefPubMed

40.

van Zijl PCM, Yadav NN (2011) Chemical exchange saturation transfer (CEST): what is in a name and what isn’t? Magn Reson Med 65:927–948CrossRefPubMedPubMedCentral

41.

Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PCM (2003) Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 50:1120–1126CrossRefPubMed

42.

Zhou J, Payen J-F, Wilson DA et al (2003) Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 9:1085–1090CrossRefPubMed

43.

Cai K, Haris M, Singh A et al (2012) Magnetic resonance imaging of glutamate. Nat Med 18:302–307CrossRefPubMedPubMedCentral

44.

Haris M, Singh A, Cai K et al (2014) A technique for in vivo mapping of myocardial creatine kinase metabolism. Nat Med 20:209–215CrossRefPubMedPubMedCentral

45.

Stares E, Rho J, Ahrens ET et al (2018) Fluorine-based contrast agents. In: Pierre VC, Allen MJ (eds) Contrast agents for MRI. The Royal Society of Chemistry, Croyden, pp 479–498

46.

Akazawa K, Sugihara F, Nakamura T et al (2018) Highly sensitive detection of caspase-3/7 activity in living mice using enzyme-responsive ¹⁹F MRI Nanoprobes. Bioconjug Chem 29:1720–1728CrossRefPubMed

47.

Schmeider AH, Caruthers SD, Keupp J et al (2015) Recent advances in ¹⁹Fluorine magnetic resonance imaging with perfluorocarbon emulsions. Engineering 1:475–489CrossRef

48.

Basal LA, Bailey MD, Romero J et al (2017) Fluorinated Eu (II)-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging. Chem Sci 8:8345–8350CrossRefPubMedPubMedCentral

49.

Srivastava K, Ferrauto G, Young VG Jr et al (2017) Eight-coordinate, stable Fe (II) complex as a dual ¹⁹F and CEST contrast agent for ratiometric pH imaging. Inorg Chem 56:12206–12213CrossRefPubMed

50.

Akazawa K, Sugihara F, Minoshima M et al (2018) Sensing caspase-1 activity using activatable ¹⁹F MRI nanoprobes with improved turn-on kinetics. Chem Commun 54:11785–11788CrossRef

51.

Nikolaou P, Goodson BM, Chekmenev EY (2015) NMR hyperpolarization techniques for biomedicine. Chem Eur J 21:3156–3166CrossRefPubMed

52.

Ardenkjæ-Larsen JH, Fridlund B, Gram A et al (2003) Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A 100:10158–10163CrossRef

53.

Kettunen MI, Kennedy BWC, Hu D-E, Brindle KM (2013) Spin echo measurements of the extravasation and tumor cell uptake of hyperpolarized [1-¹³C] lactate and [1-¹³C]pyruvate. Magn Reson Med 70:1200–1209CrossRefPubMed

54.

Bankson JA, Walker CM, Ramirez MS et al (2015) Kinetic modeling and constrained reconstruction of hyperpolarized [1-¹³C]-pyruvate offers improved metabolic imaging of tumors. Cancer Res 75:4708–4717CrossRefPubMedPubMedCentral

55.

Walker CM, Chen Y, Lai SY, Bankson JA (2016) A novel perfused Bloch–McConnell simulator for analyzing the accuracy of dynamic hyperpolarized MRS. Med Phys 43:854–864CrossRefPubMedPubMedCentral

56.

Rodrigues TB, Serrao EM, Kennedy BWC et al (2014) Magnetic resonance imaging of tumor glycolysis using hyperpolarized ¹³C-labeled glucose. Nat Med 20:93–97CrossRefPubMed

57.

Allouche-Arnon H, Lerche MH, Karlsson M et al (2011) Deuteration of a molecular probe for DNP hyperpolarization – a new approach and validation for choline chloride. Contrast Media Mol Imaging 6:499–506CrossRefPubMed

58.

Ma D, Gulani V, Seiberlich N et al (2013) Magnetic resonance fingerprinting. Nature 485:187–192CrossRef

59.

Hamilton JI, Jiang Y, Ma D et al (2018) Investigating and reducing the effects of confounding factors for robust T₁ and T₂ mapping with cardiac MR fingerprinting. Magn Reson Imaging 53:40–51CrossRefPubMedPubMedCentral

60.

Mehta BB, Coppo S, McGivney DF et al (2018) Magnetic resonance fingerprinting: a technical review. Magn Reson Med 2018:1–22

61.

Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ (2009) Preclinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 36:S56–S68CrossRefPubMed

62.

Catana C, Drzezga A, Heiss W-D, Rosen BR (2012) PET/MRI for neurologic applications. J Nucl Med 53:1916–1925CrossRefPubMed

63.

Wehrl HF, Martirosian P, Schick F, Reischl G, Pichler BJ (2014) Assessment of rodent brain activity using combined [¹⁵O]H₂O-PET and BOLD-fMRI. NeuroImage 89:271–279CrossRefPubMed

64.

Wehrl HF, Hossain M, Lankes K et al (2013) Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales. Nat Med 19:1184–1190CrossRefPubMed

65.

Hofmann M, Steinke F, Scheel V et al (2008) MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med 49:1875–1883CrossRefPubMed

66.

Gleich B, Weizenecker J (2005) Tomographic imaging using the nonlinear response of magnetic particles. Nature 435:1214–1217CrossRefPubMed

67.

Knopp T, Conolly SM, Buzug TM (2017) Recent progress in magnetic particle imaging: from hardware to preclinical applications. Phys Med Biol 62:E4–E7CrossRefPubMed

68.

Zhou XY, Jeffris KE, Yu EY et al (2017) First in vivo magnetic particle imaging of lung perfusion in rats. Phys Med Biol 62:3510–3522CrossRefPubMedPubMedCentral

69.

Kim E, Zhang J, Hong K et al (2011) Vascular phenotyping of brain tumors using magnetic resonance microscopy (μMRI). J Cereb Blood Flow Metab 31:1623–1636CrossRefPubMedPubMedCentral

70.

Calabrese E, Badea A, Cofer G, Qi Y, Johnson GA (2015) A diffusion MRI tractography connectome of the mouse brain and comparison with neuronal tracer data. Cereb Cortex 25:4628–4637CrossRefPubMedPubMedCentral

71.

Bassett DS, Brown JA, Deshpande V, Carlson JM, Grafton ST (2011) Conserved and variable architecture of human white matter connectivity. NeuroImage 54:1262–1279CrossRefPubMed

72.

Snyder ALS, Corum CA, Moeller S, Powell NJ, Garwood M (2014) MRI by steering resonance through space. Magn Reson Med 72:49–58CrossRefPubMed

Titel: Summary of Imaging in 2020: Visualizing the Future of Healthcare with MR Imaging
verfasst von: Brooke A. Corbin
Alyssa C. Pollard
Matthew J. Allen
Mark D. Pagel
Publikationsdatum: 24.01.2019
Verlag: Springer International Publishing
Erschienen in: Molecular Imaging and Biology / Ausgabe 2/2019
Print ISSN: 1536-1632
Elektronische ISSN: 1860-2002
DOI: https://doi.org/10.1007/s11307-019-01315-8

Neu im Fachgebiet Radiologie

08.04.2024 | Andrologie | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Summary of Imaging in 2020: Visualizing the Future of Healthcare with MR Imaging

Abstract

Neu im Fachgebiet Radiologie

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Quantitative Angiografie könnte IVUS-Alternative darstellen

Die Ganz-Genom-Sequenzierung startet

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

In Vivo Mapping and Quantification of Creatine Using Chemical Exchange Saturation Transfer Imaging in Rat Models of Epileptic Seizure

Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models

Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy

Test-Retest Stability of Cerebral 2-Deoxy-2-[18F]Fluoro-D-Glucose ([18F]FDG) Positron Emission Tomography (PET) in Male and Female Rats

Mapping Bone Marrow Response in the Vertebral Column by Positron Emission Tomography Following Radiotherapy and Erlotinib Therapy of Lung Cancer

Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[11C]Methylpurine in Mice

Neu im Fachgebiet Radiologie

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Quantitative Angiografie könnte IVUS-Alternative darstellen

Die Ganz-Genom-Sequenzierung startet

Update Radiologie